Capital Fund Management (CFM)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,378
Closed -$252K 2106
2025
Q4
$252K Buy
+13,378
New +$224K ﹤0.01% 2306
2025
Q3
Sell
-91,848
Closed -$1.79M 2475
2025
Q2
$1.79M Sell
91,848
-37,242
-29% -$662K ﹤0.01% 1737
2025
Q1
$2.29M Buy
129,090
+6,085
+5% +$131K 0.01% 1367
2024
Q4
$2.63M Buy
+123,005
New +$2.99M 0.01% 1375
2021
Q2
Sell
-16,949
Closed -$1.15M 1447
2021
Q1
$1.15M Buy
+16,949
New +$1.32M 0.01% 931
2019
Q4
Sell
-9,100
Closed -$206K 1839
2019
Q3
$206K Buy
+9,100
New +$252K ﹤0.01% 1574

Other funds holding CDNA

Capital Fund Management (CFM)'s CDNA Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of CareDx (CDNA) in Q1 2026, closing a stake of 13,378 shares — an estimated $252K sold.

Capital Fund Management (CFM) first reported a position in CDNA in Q3 2019 and held it in 6 quarters. The position peaked at $2.63M in Q4 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 13,378 CareDx shares in Q1 2026, an estimated $252K.
  • Capital Fund Management (CFM) first reported a position in CareDx in Q3 2019 and held it in 6 quarters.
  • Capital Fund Management (CFM)'s CareDx position peaked at $2.63M in Q4 2024.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.